Issue #3
-
Experts to explore clinical controversies in early nonmetastatic breast cancer
Lisa Carey, MD, ScM, FASCO, will moderate Thursday afternoon discussions on axillary management of patients with breast cancer, treating small triple-negative breast cancer, and more.
-
State-of-the-Art Session to focus on role of senescence
Justin Balko, PharmD, PhD, will moderate a Thursday afternoon exploration of senescence in breast cancer and its role in immune microenvironment and therapeutic response.
-
Poster Spotlight Session 10: Refining Prediction of Cancer Risk and Outcomes – Presenter Profiles
Mikael Eriksson, PhD, and Kelly-Anne Phillips, MBBS, MD, FRACP, discuss their Thursday morning poster presentations.
-
Poster Spotlight Session 12: Putting Brakes on the Cell Cycle: Understanding Mechanisms Governing CDK 4/6 inhibitor Resistance and Role for Novel Therapeutic Strategies – Presenter Profile
Barbara Pistilli, MD, discusses a Thursday morning poster presentation analyzing the CAPItello-292 Phase 1b trial.
-
Rapid-fire Session 2: Mini-Oral Presentations – Presenter Profiles
Amy Tiersten, MD, and Akihiko Shimomura, MD, PhD, discuss their Thursday poster presentations.
-
Social determinants of health must be addressed to improve patient outcomes
On Tuesday, December 5, panelists discussed how cancer outcomes can be adversely affected by environmental, social, cultural, psychological, clinical, biological, genetic, and behavioral factors.
-
SABCS® Daily Highlights for Wednesday, December 6
SABCS® Co-Director Carlos Arteaga, MD, shares a few highlights from Wednesday’s schedule to help you plan your day, including cutting-edge oral and poster presentations, interactive educational sessions, and more.
-
Wednesday General Session and Poster Spotlight Session presentations
Don’t miss Wednesday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
-
Panel discussion to explore frontier of breast cancer immunotherapy
Sherene Loi, MD, PhD, will moderate a Wednesday afternoon State-of-the-Art Session on purpose, resistance, and toxicity of immunotherapeutic approaches in breast cancer.
-
Controversies in Locoregional Care – Presenter Profile
Icro Meattini, MD, discusses a Wednesday afternoon presentation on patient-friendly radiation courses with whole breast and partial breast irradiation.